Novel Mucosal Adjuvant for an HIV DNA Vaccine

Project: Research project

Project Details

Description

Novel Mucosal Adjuvant for an HIV DNA Vaccine Novel Mucosal Adjuvant for an HIV DNA Vaccine
StatusFinished
Effective start/end date7/1/166/30/19

Funding

  • HHS-NIH: National Institute of Allergy & Infectious Diseases (NIAID): $152,142.00

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.